Table 1 Baseline patient characteristics by stages of CKD.
From: Male sexual dysfunction in patients with chronic kidney disease: a cross-sectional study
|  | Overall (N = 72) | CKD 1–2 (N = 39) | CKD 3a–3b (N = 15) | CKD 4–5 (N = 18) | P value |
|---|---|---|---|---|---|
Demographics | |||||
Age, y | 43.94 ± 8.93 | 40.90 ± 8.10 | 50.20 ± 6.54 | 45.33 ± 9.65 | 0.001 |
Marital status (Married, %) | 63 (87.50) | 32 (82.10) | 15 (100.00) | 16 (88.90) | 0.199 |
Weight, kg | 68.86 ± 10.76 | 68.15 ± 12.12 | 70.37 ± 9.76 | 69.17 ± 8.59 | 0.791 |
Height, cm | 168.71 ± 5.37 | 168.44 ± 5.80 | 168.60 ± 4.90 | 169.39 ± 5.00 | 0.825 |
BMI, kg/m2 | 24.18 ± 3.59 | 23.98 ± 3.98 | 24.75 ± 3.25 | 24.14 ± 3.08 | 0.780 |
Smoking status (%) | |||||
 Current smoker | 12 (16.70) | 5 (12.90) | 3 (20.00) | 4 (22.20) | 0.032 |
 Ex-smoker | 10 (13.90) | 1 (2.60) | 5 (33.30) | 4 (22.20) |  |
 Never | 50 (69.40) | 33 (84.60) | 7 (46.70) | 10 (55.60) |  |
Drinking status (%) | |||||
 Current drinker | 13 (18.10) | 7 (17.90) | 4 (26.70) | 2 (11.10) | 0.270 |
 Ex-drinker | 10 (13.90) | 3 (7.70) | 2 (13.30) | 5 (27.80) |  |
 Never | 49 (68.10) | 29 (74.40) | 9 (60.00) | 11 (61.10) |  |
Renal function | |||||
 Scr, μmol/L | 246.72 ± 311.03 | 92.84 ± 18.06 | 143.61 ± 22.91 | 666.06 ± 391.12 | < 0.001 |
 eGFR, mL/min/1.73 m2 | 62.22 ± 36.24 | 89.96 ± 19.11 | 49.97 ± 8.53 | 12.32 ± 8.66 | < 0.001 |
 ACR, mg/L | 1256.50 | 648.42 | 874.61 | 2892.25 | < 0.001 |
 BuN, mmol/L | 10.11 ± 8.65 | 5.21 ± 1.20 | 8.29 ± 5.17 | 22.22 ± 8.60 | < 0.001 |
 BUA, μmol/L | 410.63 ± 136.26 | 387.27 ± 102.33 | 440.77 ± 105.83 | 436.12 ± 205.36 | 0.289 |
Comorbidities (%) | |||||
 Hypertension | 44 (61.10) | 18 (46.20) | 9 (60.00) | 17 (94.40) | 0.002 |
 Diabetes mellitus | 11 (15.30) | 2 (5.10) | 2 (13.30) | 7 (38.90) | 0.004 |
 Chronic prostatitis | 4 (5.60) | 4 (10.30) | 0 (0.00) | 0 (0.00) | 0.167 |
 Benign Prostate Hyperplasia | 4 (5.60) | 0 (0.00) | 2 (13.30) | 2 (11.10) | 0.079 |
Medication regimen (%) | |||||
 ACEI/ARB | 25 (34.70) | 16 (41.00) | 6 (40.00) | 3 (16.70) | 0.178 |
 CCB | 18 (25.00) | 1 (2.60) | 5 (33.30) | 12 (66.70) |  < 0.001 |
 β-blockers | 9 (12.50) | 1 (2.60) | 0 (0.00) | 8 (44.40) |  < 0.001 |
 ISA | 24 (33.30) | 18 (46.20) | 3 (20.00) | 3 (16.70) | 0.042 |
 ULT | 28 (38.90) | 12 (30.80) | 5 (33.30) | 11 (61.10) | 0.081 |
 SGLT2 | 2 (2.80) | 1 (2.60) | 1 (6.70) | 0 (0.00) | 0.506 |
 Other hypoglycemic drugs | 5 (6.90) | 2 (5.10) | 1 (6.70) | 2 (11.10) | 0.71 |
Psychological factor | |||||
 Depression | 7.12 ± 5.76 | 6.08 ± 4.94 | 5.07 ± 5.26 | 11.11 ± 6.19 | 0.002 |
 Anxious | 3.24 ± 3.18 | 3.08 ± 3.24 | 2.73 ± 2.58 | 4.00 ± 3.51 | 0.476 |
